What is the Drug Therapy for Migraine?

Drug therapy for migraine, divided into acute (abortive) and preventive (prophylactic) treatments:

1. Acute (Abortive) Migraine Treatment

Used during a migraine attack to relieve symptoms.

a. Analgesics / NSAIDs

  • Examples: Ibuprofen, Naproxen, Aspirin, Acetaminophen
  • Best for mild to moderate migraines
  • Often combined with antiemetics (e.g., metoclopramide)

 b. Triptans (1st line for moderate-severe)

  • Examples: Sumatriptan, Rizatriptan, Zolmitriptan
  • Mechanism: 5-HT₁B/₁D agonists → vasoconstriction & reduced neurogenic inflammation
  • Avoid with:
    • CAD, stroke, uncontrolled HTN
    • Ergotamine (within 24 hrs)
    • MAO inhibitors (within 2 weeks for some)

 c. Ergot Alkaloids

  • Examples: Ergotamine, Dihydroergotamine (DHE)
  • Older agents, less commonly used now
  • Avoid with: CYP3A4 inhibitors, pregnancy, triptans

d. Antiemetics

  • Examples: Metoclopramide, Prochlorperazine
  • Used for nausea/vomiting and to enhance absorption of oral meds

e. New options

  • Gepants (CGRP antagonists): Ubrogepant, Rimegepant
  • Ditans (5-HT1F agonist): Lasmiditan
    • Good for patients with cardiovascular risk (no vasoconstriction)

2. Preventive (Prophylactic) Treatment

Used to reduce frequency/severity of migraines. Indicated if:

  • ≥4 migraine days/month
  • Debilitating attacks
  • Poor response to abortive meds

 a. Beta-blockers

  • Examples: Propranolol, Metoprolol
  • First-line for many patients

 b. Anticonvulsants

  • Examples: Topiramate, Valproate
  • Topiramate: also causes weight loss (good in obesity)
  • Valproate: avoid in pregnancy

 c. Antidepressants

  • Examples: Amitriptyline (TCA), Venlafaxine (SNRI)
  • Good if comorbid depression, anxiety, or insomnia

 d. CGRP inhibitors

  • Examples: Erenumab, Fremanezumab, Galcanezumab
  • Monoclonal antibodies targeting calcitonin gene-related peptide (CGRP)
  • Given monthly (injection)

 e. Others

  • Botox: for chronic migraine (≥15 days/month)
  • Lifestyle: sleep, hydration, stress, trigger avoidance

Presentation for Drug Therapy for Migraine

                                                                 END OF THE CHAPTER

You may also like read more: 

SHARE

Owner

Hi. I’m Writer of Researchsop.com. ’ ’ Please share these SOPs to all concern pharma people for their development. I like to fullfill the need of curious people. These things inspire me to make things looks better.

  • Image
  • Image
  • Image
  • Image
  • Image
    Blogger Comment
    Facebook Comment

0 comments:

Post a Comment